(HealthDay News) -- In a phase 3 clinical trial, an experimental immune-based treatment boosted by 20 percent the overall survival of those with tough-to-treat neuroblastoma, which affects mostly children.
The findings are to be presented at the American Society for Clinical Oncology annual meeting, which starts later this month in Florida.
The trial involved 226 patients newly diagnosed with high-risk neuroblastoma, a cancer of the nervous system. Standard treatment includes surgery, aggressive chemotherapy with "stem cell rescue" (where the patient's stem cells are removed before treatment, then returned after chemotherapy to boost blood/immune function) and radiation therapy.
"Even though we treat it with aggressive therapy, high-risk neuroblastoma often returns, and most patients do not survive," Dr. Alice Yu, a professor of hematology/oncology at the University of California, San Diego, and the school's Moores Cancer Center, said in a news release from the society. Read more...
Immunice for Immune Support
Showing posts with label Immune Therapy May Aid Kids With Neuroblastoma. Show all posts
Showing posts with label Immune Therapy May Aid Kids With Neuroblastoma. Show all posts
Wednesday, March 21, 2012
Subscribe to:
Posts (Atom)
Health Begins In The Colon$19.99  The REAL Secret to Health is Finally Revealed! Did you know that disease starts and health begins in the colon? You can read more about how to better your health in Dr. Group's exclusive book |